Biostax Corp.

BTAX · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
Assets
Cash & Equivalents$0-$0$2
Short-Term Investments$0$0$0
Receivables$0$0$0
Inventory$0$0$0
Other Curr. Assets$0$0$0
Total Curr. Assets$0-$0$2
Property Plant & Equip (Net)$0$0$0
Goodwill$0$0$0
Intangibles$0$0$0
Long-Term Investments$0$0$0
Tax Assets$0$0$0
Other NC Assets$6$6$6
Total NC Assets$6$6$6
Other Assets$0$0$0
Total Assets$6$5$8
Liabilities
Payables$1,259$1,256$1,352
Short-Term Debt$1,161$1,170$1,243
Tax Payable$0$0$0
Deferred Revenue$0$0$0
Other Curr. Liab.$32$161$0
Total Curr. Liab.$5,329$5,308$4,867
LT Debt$0$0$0
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$0$0$0
Total NC Liab.$0$0$0
Other Liabilities$0$0$0
Cap. Leases$0$0$0
Total Liabilities$5,329$5,308$4,867
Equity
Pref Stock$0$0$0
Common Stock$8$8$8
Retained Earnings-$386,148-$386,112-$385,668
AOCI$0$0$0
Other Equity$0$0$0
Total Equity-$5,324-$5,303-$4,859
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$6$5$8
Net Debt$1,161$1,170$1,241